Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6682800 | 0.75 | HTR2C (0.50) | HTR2CNAAA | |
| Trifluoroacetic Acid SCHEMBL30293182 | 0.75 | CA12 (0.34) | CA12CA1CA2CA9 | |
| Hydrochloric Acid SCHEMBL11847967 | 0.71 | HTR2C (0.52) | HTR2CNAAA | |
| SCHEMBL5496994 | 0.71 | HTR2C (0.45) | HTR2CNAAA | |
| Trifluoroacetic Acid SCHEMBL27519761 | 0.71 | CYP1A2 (0.45) | HDAC1 | |
| Trifluoroacetic Acid SCHEMBL10952565 | 0.71 | HTT (0.43) | CA1CA2CA9 | |
| SCHEMBL18249514 | 0.69 | HTR2C (0.46) | CA12CA1CA2CA9HTR2C | |
| Hydrochloric Acid SCHEMBL28234487 | 0.69 | HTR2C (0.44) | HTR2CNAAA | |
| SCHEMBL30782968 | 0.69 | NFKB1 (0.50) | HTR2CHDAC1HDAC2 | |
| SCHEMBL18295865 | 0.68 | HTR2C (0.48) | CA12CA1CA2CA9HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002053526-A1 | NEW COMPOUNDS FOR USE AS INTERMEDIATES IN LINEAR BLOCK POLYMER AND NEW LINEAR BLOCK POLYMER | ARTIMPLANT AB (SE) | 2002-07-11 | — | — | WO | disclosed |